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Abstract: Excess energy intake can trigger an uncontrolled inflammatory response, leading to
systemic low-grade inflammation and metabolic disturbances that are hypothesised to contribute to
cardiovascular disease and type 2 diabetes. The long chain n-3 polyunsaturated fatty acids (LC n-3
PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are suggested to mitigate this
inflammatory response, but the mechanisms are unclear, especially at the tissue level. Adipose tissues,
the first tissues to give an inflammatory response, may be an important target site of action for EPA
and DHA. To evaluate the effects of EPA and DHA in white and brown adipose tissues, we fed
male C57Bl/6J mice either a high fat diet (HFD) with 5% corn oil, an HFD with 40% of the corn
oil substituted for purified EPA and DHA triglycerides (HFD-ED), or normal chow, for 8 weeks.
Fatty acid profiling and transcriptomics were used to study how EPA and DHA affect retroperitoneal
white and brown adipose tissues. HFD-ED fed mice showed reduced lipid accumulation and levels of
the pro-inflammatory fatty acid arachidonic acid in both white and brown adipose tissues, compared
with HFD-corn oil fed animals. The transcriptomic analysis showed changes in β-oxidation pathways,
supporting the decreased lipid accumulation in the HFD-ED fed mice. Therefore, our data suggests
that EPA and DHA supplementation of a high fat diet may be anti-inflammatory, as well as reduce
lipid accumulation in adipose tissues.
Keywords: eicosapentaenoic acid (EPA); docosahexaenoic acid (DHA); brown and white adipose
tissue; gene expression profiling; signaling pathway; inflammation
1. Introduction
Obesity is characterized by excessive fat accumulation accompanied by weight gain, and often
induces chronic low-grade inflammation, which in turn is a risk factor for type 2 diabetes (T2D),
cardiovascular diseases (CVD), and other metabolic abnormalities [1]. Obesity is caused by excessive
energy intake, and white adipose tissue (WAT), as the main storage organ for excess energy in the form
of lipids, also activates an inflammatory response to excess energy intake [2]. The problem with obesity
may be exacerbated by a decreased capability to dissipate energy through adaptive thermogenesis
in brown adipose tissue (BAT) [3]. An important aspect to the role of adipose tissue in obesity is
that WAT can transiently turn to beige adipocytes [4], which can use surrounding lipids through
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mitochondrial thermogenesis via uncoupling protein. This process is affected by gender [5] and external
cues including environmental temperature [6]. Furthermore, it has recently been demonstrated that
omega-3 long chain PUFA supplementation has a beneficial effect on the thermogenic function of
adipocytes and compensates for the inhibitory effect of omega-6 long chain PUFA on the thermogenic
function [7,8].
From a nutritional perspective, not only the quantity, but also the quality of dietary lipids may be
an important factor in the development of obesity-related disease. For example, dietary lipid chain
length and saturation can influence the metabolism [9,10]. A typical westernized diet often includes
an excessive amount and proportion of saturated fatty acids, which increase the risk of CVD and
provides too low levels of long chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs) compared to
n-6 PUFAs [11–13]. LC n-3 PUFAs are suggested to aid in preventing or ameliorating inflammatory
diseases, autoimmune diseases, and consequently the risk of CVD [13,14]. Supplementation with fish
oil, which is a major source of the n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid (EPA
and DHA) has been suggested to prevent T2D [15], while some studies have found that marine fatty
acids have no [16] or inconclusive effects on metabolic syndrome [17]. A reason for these conflicting
findings may be confounding factors from other dietary components including other lipids present in
fish oil, as reported in several rodent studies [18–20].
As adipose tissues are known to play an important role in the pathogenesis of obesity and related
disorders [21,22], we hypothesised that a diet enriched with EPA and DHA would impact upon gene
expression in adipose tissue which may help explain some of the findings related to human health.
In order to understand this, we used transcriptomics to measure the gene expression in BAT and WAT
from mice fed a high fat diet (HFD) supplemented with 5% of corn oil or the same HFD except with
40% of the corn oil substituted with EPA and DHA enriched triglycerides as a model of diet induced
obesity. Furthermore, we have used EPA and DHA enriched oil, rather than fish oil, to reduce the
confounding, which may come from the presence of many other compounds besides EPA and DHA in
fish oil. This makes it possible to attribute the effects more specifically to these LC n-3 PUFAs.
2. Results
Mice were fed with standard control chow during their acclimatization period and the mice did
not differ in body weight at the start of the study (Table 1). The intervention study used three groups
of mice that were fed either standard chow (control group; n = 11) HFD-corn oil (n = 12), or HFD-ED
(n = 12). Two mice were removed from the control diet group due to fighting, hence there were n = 9
and n = 12 mice in control and each HFD groups, respectively. The differing HFDs differed only in
their composition of fatty acids (FA) (Table 2), based on the replacement of 40 % of the corn oil with
oil enriched with EPA and DHA, representing 2 % of the total diet weight and 13 % of total fat in the
feed. In total, the control diet provided 24 energy% (E%) protein, 12 E% fat and 65 E% carbohydrates,
whereas both the HFD provided 25 E% protein, 32 E% fat and 44 E% carbohydrates (Table 2).
Table 1. Changes in body weight of the mice fed control (n = 9), high fat diet—EPA and DHA (HFD-ED)
(n = 12), or high fat diet—corn oil (HFD-corn oil) (n = 12). Letters a and b denotes significant difference
p ≤ 0.05
Parameter Control HFD-ED HFD-Corn Oil
Initial body weight (g) 27.50 ± 0.80 28.60 ± 0.80 24.30 ± 0.50
Final body weight (g) 31.40 ± 1.00 33.80 ± 0.80 36.20 ± 0.90
Change in body weight (g) 3.90 ± 0.50 a 5.20 ± 0.30 a 8.60 ± 0.50 b
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Table 2. Composition of control, high fat diet— eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) (high fat diet (HFD)-ED), or high fat diet—corn oil (HFD-CO) diet [23].
Ingredient (g/100 g Diet) Control HFD-ED HFD-CO
Protein Casein 22.20 25.60 25.60
Carbohydrates Sucrose 5.00 10.00 10.00
Corn starch 56.00 34.80 34.80
Cellulose 5.00 5.80 5.80
Fat Total 5.00 15.00 15.00
Corn oil 2.50 3.00 5.00
Coconut oil 2.50 10.00 10.00
EPAX oils a 0.00 2.00 0.00
Minerals b 2.00 2.50 2.50
Micro nutrients c 3.00 3.00 3.00
Choline bitartrate 1.60 2.00 2.00
Cholesterol 0.00 1.00 1.00
Methionine 0.20 0.30 0.30
Energy content (kJ/100g) 1599 1752 1752
Protein E% 24 25 25
Carbohydrate E% 65 44 44
Fat E% 12 32 32
Fatty acid composition d (mg/g diet)
C10:0 0.20 1.47 1.33
C12:0 2.37 7.58 7.72
C14:0 1.54 4.58 4.78
C16:0 1.90 3.44 3.59
C18:0 0.68 2.26 2.49
SFA 6.70 19.33 19.91
C18:1 n-9 2.82 4.80 5.26
MUFA 2.82 4.80 5.26
C18:2 n-6 3.62 5.03 7.36
C18:3 n-6 0.12 0.22 0.26
Total n-6 PUFA 3.74 5.26 7.62
C20:5 n-3 (EPA) 0.00 2.03 0.01
C22:6 n-3 (DHA) 0.00 4.58 0.01
Total n-3 PUFA 0.00 6.61 0.02
a EPAX 1050. EPAX 6015; b CaCO3 (57.7%); KCl (19.9%); KH2PO4 (11.9%); MgSO4 (10.4%); c Corn starch (98.22%);
Ca(IO3)2 (0.0007%); CoCO3 (0.064%); CuO (0.02%); FeSO4 (0.5%); MnO2 (0.035%); Na2MoO4 (0.001%); NaSeO3
(0.0007%); ZnO (0.1%); Vitamin A (0.013%); B2 (Riboflavin-5-phosphate sodium; 0.027%); B3 (0.1%); B5 (Ca
Pantothenate; 0.057%); B6 (0.023%); B7 (0.0007%); B9 (0.007%); B12 (0.00008%); D3 (0.007%); E (0.25%); K (0.003%);
d Diet analyses of fatty acids were performed in triplicates, and the data was obtained by gas chromatography
mass spectroscopy.
2.1. Physiological Changes Induced by HFD-ED in Brown- and White Adipose Tissues
After 8 weeks of dietary intervention, we observed delayed weight gain in mice fed HFD-ED
compared with HFD-corn oil (Table 1) even though the mice were fed isoenergetic diets similar in
macronutrients only differing in the source of 13 % of the total fat content. Furthermore, relative tissue
weight of BAT (Figure 1a) and WAT (Figure 1b) from the mice fed HFD-ED was 76 % (BAT) and 58
% (WAT) compared to feeding the mice with HFD-corn oil. No difference between the HFD-ED and
control diet fed mice was observed (Figure 1).
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Figure 1. Physiological changes in adipose tissues upon dietary intervention. (a) Brown adipose 
tissue: Effects of 8 weeks of diet intervention on brown adipose tissue (BAT), represented as BAT to 
body weight ratio. (b) White adipose tissue: Effects of 8 weeks diet intervention on white adipose 
tissue (WAT), represented as WAT to body weight ratio. For 8 weeks dietary intervention: n = 10, 12, 
12; control, high fat diet (HFD corn oil with 40% substituted with EPA and DHA (HFD-ED) and HFD-
corn oil (HFD-CO), respectively. * asterisk denotes significant difference between evaluated groups 
by Tukey’s multiple comparison test. Data are shown as mean ± SEM and p-value < 0.05 was 
considered significant. 
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fed HFD-ED compared with either HFD-corn oil or control diet, whereas C16:0 was higher for the 
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in HFD-corn oil fed compared to control diet, and C20:4 n-6 (arachidonic acid) was lower in HFD-ED 
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including linoleic acid and arachidonic acid was lower in the mice fed HFD-ED compared with the 
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(Figures 2 and 3). Among the SFA in BAT and WAT, the relative abundance of C12:0 and C14:0 was 
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Figure 1. Physiological hanges in adipose tissue upon dietary interv ntion. (a) Brown adipose
tissue: Effects of 8 weeks of diet interv ntion brown adipose tissue (BAT), represented as BAT to
body weight ratio. (b) White adipose tissue: Effects of 8 weeks diet nterv ntion on white adipose
tissue (WAT), represented as WAT to b dy weight ratio. For 8 we ks dietary inter ti = 10,
12, 12; control, hi ( corn oil with 40% substituted with EPA and DHA (HFD-ED) and
HFD-corn oil (HFD-CO), respectively. * asterisk denotes significant difference b tween evaluated
groups by Tukey’s multiple comparison test. Data are sho n ± SEM and p-value < 0.05 was
considere significant.
2.2. Fatty Acid Composition of the Brown and White Adipose Tissues
The neutral lipid fraction: The relative abundance of n-3 PUFAs, including C20:5 n-3 (EPA), C22:5
n-3 (docosapentaenoic acid; DPA) and C22:6 n-3 (DHA), were higher in both WAT and BAT from
the mice fed HFD-ED compared with either control or HFD-corn oil (Figures 2 and 3). In BAT and
WAT, the relative abunda ce of saturated fatty acids (SFA) C12:0 and C14:0 was higher in the mice
fed HFD-E compared with either HFD-corn oil r control diet, whereas C16:0 was higher for the
comparison HFD-E vs HFD-corn oil nly in WAT (Figures 2 and 3). In WAT, the mon unsaturated
fatty cid (MUFA) C18:1 n-9 was lowest in HFD-ED fed mice ompared with e r maining two diets
(Figure 3). The relative abunda ce of n-6 PUFAs in BAT, including C18:2 n-6 (linoleic a id) was higher
in HFD-corn il fed compared to control diet, and C20:4 n-6 (arachidonic a id) was lower in HFD-ED
compared with control and HFD-corn oil fed animals (Figure 2). The amount of n-6 PUFAs in WAT,
including lino eic acid and arachidonic acid was lower in the mice f d HFD-ED compared with the
mice fed eith r the contr l or HFD-corn oil (Figure 3).
Free fatty acids: In BAT and WAT, LC n-3 PUFAs including EPA, DPA, and DHA were higher in
both the adipose tissues from the mice fed HFD-ED compared with control or HFD-c rn oil (Figures 2
and 3). Among the SF in BAT and WAT, the relative abundance of C12:0 and C14:0 was higher in
the mice fed HFD-ED compared with either HFD-corn oil or control diet, whereas the abundance of
C16:0 was higher for the comparison HFD-ED vs. HFD-corn oil in BAT and in WAT (Figures 2 and 3).
The MUFA including C18:1 n-9 and C18:1 n7 were lowest in the HFD-ED fed mice compared with
HFD-corn oil or control fed animals (Figures 2 and 3). However, the relative abundance of linoleic acid
and arachidonic acid was lower in the WAT from the mice fed HFD-ED compared with HFD-corn oil
(Figure 3).
The phospholipid fraction: In BAT, the relative abundance of LC n-3 PUFAs including EPA and
DHA was remarkable in HFD-ED compared to the control and HFD-corn oil (Figure 2). Interestingly,
the amount of EPA did not differ in the WAT from the mice fed HFD-ED, but the DHA amount was
higher in HFD-ED fed mice compared with the control and HFD-corn oil fed mice (Figure 3). Moreover,
in BAT, the C16:0 was higher in HFD-ED fed animals compared to HFD-corn oil and the C18:0 was
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lower in HFD-corn oil compared with control fed animals and HFD-ED fed mice (Figure 2). The relative
abundance of n-6 PUFAs in BAT, including the C20:4 n-6 (arachidonic acid) was lower in HFD-ED
compared with control and HFD-corn oil fed animals (Figure 2). Also, arachidonic acid levels were
lower in the WAT of the mice fed HFD-ED compared with control and HFD-corn oil (Figure 3).
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Figure 2. BAT.Fatty acids methyl esters (FAME) composition is shown as mean ± SEM and as a relative
percentage of total lipid fractions in order of increasing number of carbon-chain length of respective
fatty acid. n3 and n6 denotes omega-3 and omega-6 fatty acids, respectively. White bar control, black
bar HFD-ED, grey bar HFD-corn oil (top) BAT neutral lipid fraction and FAME composition, (middle)
BAT free fatty acid fraction and FAME composition, (bottom) BAT phospholipid fraction and FAME
composition, from the mice fed either control diet (BAT n = 5), HFD-ED (BAT n = 8) or HFD-corn oil
(BAT n = 12) after 8-week dietary intervention. The significance is denoted by different letters and
the statistical difference was tested by ANOVA followed by Tukey’s multiple comparison test where
letter a = p-value < 0.05 between HFD-corn oil vs. control diet; b = p-value < 0.05 between HFD-ED vs.
control diet; c = p-value < 0.05 between HFD-ED vs. HFD-corn oil.
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control, black bar HFD-ED, grey bar HFD-corn oil (top) WAT neutral lipid fractions and FAME 
composition, (middle) WAT free fatty acid fraction and FAME composition, (bottom) WAT 
phospholipid fraction and FAME composition, from the mice fed either control diet (WAT n = 7), 
HFD-ED (WAT n = 10) or HFD-corn oil (WAT n = 11) after 8-week dietary intervention. The 
significance is denoted by different letters and the statistical difference was tested by ANOVA 
followed by Tukey’s multiple comparison test where letter a = p-value < 0.05 between HFD-corn oil 
vs. control diet; b = p-value < 0.05 between HFD-ED vs. control diet; c = p-value < 0.05 between HFD-
ED vs. HFD-corn oil. 
2.3. Transcriptomic Differences between HFD-ED and HFD-Corn Oil Fed Mice. 
For the assessment of the effects of different HFD-ED and HFD-corn oil diets on BAT and WAT, 
differential gene-expression was analysed for the following comparisons: Comparing the two HFDs, 
Figure 3. WAT.Fatty acids methyl esters (FAME) composition is shown as mean ± SEM and as a relative
percentage of total lipid fractions in order of increasing number of carbon-chain length of respective
fatty acid. n3 and n6 denotes omega-3 and omega-6 fatty acids, respectively. White bar control, black
bar HFD-ED, grey bar HFD-corn oil (top) WAT neutral lipid fractions and FAME composition, (middle)
WAT free fatty acid fraction and FAME composition, (bottom) WAT phospholipid fraction and FAME
composition, from the mice fed either control diet (WAT n = 7), HFD-ED (WAT n = 10) or HFD-corn oil
(WAT n = 11) after 8-week dietary intervention. The significance is denoted by different letters and
the statistical difference was tested by ANOVA followed by Tukey’s multiple comparison test where
letter a = p-value < 0.05 between HFD-corn oil vs. control diet; b = p-value < 0.05 between HFD-ED vs.
control diet; c = p-value < 0.05 between HFD-ED vs. HFD-corn oil.
2.3. Transcriptomic Differences between HFD-ED and HFD-Corn Oil Fed Mice.
For the assessment of the effects of different HFD-ED and HFD-corn oil diets on BAT and WAT,
differential gene-expression was analysed for the following comparisons: Comparing the two HFDs,
HFD-corn oil differently regulated 1441 genes in WAT (Figure 4) and 418 genes in BAT compared to
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HFD-ED (Figure 4) after 8 weeks of dietary intervention. HFD-ED vs. control and HFD-corn oil vs.
control were also investigated. From these comparisons, it was observed that HFD-corn oil showed
most differential expressed genes (DEGs) in BAT (970 genes; Figure 4) and WAT (1490 genes; Figure 4)
compared with control diet fed animals, whereas HFD-ED differed for fewer genes in BAT (446 genes;
Figure 4) and WAT (309 genes; Figure 4) compared to control diet fed animals. This fits with the lower
fat accumulation in HFD-ED animals compared to HFD-corn oil animals, and there was no difference
between fat accumulation in HFD-ED and control diet fed groups.
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Based on KEGG pathway analysis, the two different HFD affected in a diverse range of 
pathways. In BAT, the top regulated pathways involve metabolic activity such as carbon and fatty 
acid metabolism, hormone signalling, protein degradation and processing (Figure 5). In WAT, the 
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Figure 4. Venn diagram of differentially regulated genes at the cut off of the p-value < 0.001 after
8-week dietary intervention. (Left) Venn diagram depicting overlaps among differentially expressed
genes in BAT upon dietary intervention. Most regulation can be seen for comparison HFD-corn oil vs.
control diet (CO vs. CD) = blue and HFD-ED vs. HFD-corn oil (ED vs. CO) = yellow, whereas HFD-ED
vs. control diet (ED vs. CD) = red shows comparatively less bidirectional differentially regulated genes.
(Right) Venn diagram depicting overlaps among differentially expressed genes in WAT upon dietary
intervention. Most regulation can be seen for comparison HFD-corn oil vs. control diet (CO vs. CD)
and HFD-ED vs. HFD-corn oil (ED vs. CO), whereas HFD-ED vs. control diet (ED vs. CD) shows least
bidirectional differentially regulated genes.
Based on KEGG pathway analysis, the two different HFD affected in a diverse range of
pathways. In BAT, the top regulated pathways involve metabolic activity such as carbon and fatty
acid metabolism, hormone signalling, protein degradation and processing (Figure 5). In WAT, the top
regulated pathways involve metabolic activities such as oxidative phosphorylation, citric acid cycle,
glycolysis/gluconeogenesis. Also, signalling pathways, biosynthesis, and degradation (valine, leucine,
and isoleucine) of amino acids (Figure 5).
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2.4. GO-Terms Gene-Set Enrichment Analyses of Biological Processes Affected by the HFD Diets in White- and
Brown Adipose Tissues
In WAT, HFD-ED up-regulated BPs related to mitochondria including electron transport chain,
fatty acid β-oxidation, mitochondrial-translation, and organization, whereas, these processes were
down-regulated by HFD-corn oil compared with control animals (Figure 6). Furthermore, BPs related to
phospholipid- and cholesterol eﬄux and lipoprotein metabolic processes were strongly down-regulated
by HFD-ED but up-regulated by HFD-corn oil compared with control fed mice. Immune related BPs
were down-regulated in HFD-ED fed mice including inflammatory response including acute phase,
antigen processing and presentation, immunoglobulin-mediated immune response, response to tumor
necrosis factor, but were up-regulated in HFD-corn oil fed mice compared with control mice.
One distinct BP, fatty acid beta-oxidation using acyl-CoA dehydrogenase was up-regulated by
HFD-ED compared with HFD-corn oil. BPs related to skeletal muscle fibre development, and regulation
of muscle contraction were among those up-regulated by both HFDs, and among down-regulated were
BPs related to mitochondrial organization, and fatty acid metabolic processes including biosynthesis of
fatty acid, phospholipid, cardiolipin, cholesterol and sterol (Figure 6).
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2.5. Differential Expression of Pparα and Prdm16 in BAT and WAT in Response to HFD-ED
The gene expression of Ppar-α involved in β-oxidation was significantly higher in response to
the HFD-ED compared to the control, such an effect was absent in the HFD-CO group, Figure 7.
A small but significant effect of HFD-ED vs. the control diet on the expression of Prdm16, involved in
thermogenesis, was also observed. No effect of HFD-ED or HFD-CO on Ppar-α or Prdm16 in WAT was
detected. The only effect of the HFDs in WAT was a small, but significant, effect of HFD-CO on the
gene Ppar γ1a involved in lipogenesisInt. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 11 of 18 
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third animal did not pass the quality check. Also data on Prdm16 in the WAT control diet group was 
based on n = 2 (missing value). 
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Figure 7. RNA expression of Pparα, Pparγ1a and Prdm16 in (a) BAT and (b) WAT in response to
HFD-ED and HFD-CO relative to the control diet. All data for BAT are mean values of 3 tissues (n = 3).
WAT RNA expression in the HFD-ED group was based on 2 animals due to that the RNA from the
third animal did not pass the quality check. Also data on Prdm16 in the WAT control diet group was
based on n = 2 (missing value).
3. Discussion
LC n-3 PUFAs, especially EPA and DHA are proposed to have beneficial effects on human health,
that might be explained by their hypolipi emic and anti-inflammatory properties in mammals [23,24].
Undoubtedly, there are a number of factors contributing to the magnitude, and type of effects caused by
EPA and DHA supplementation, such as population heterogeneity, dose, backgr und lipid s atus and
diet [18,20]. In this tudy, male C57Bl/6J mice fed an HFD (i) wit 5% c rn oil a d (ii) 3% corn oil and
2% EPA a DHA enriched oils, similar in to al energ led to the differences in weight gain [23] also
observed i [25]. EPA and DHA supplementation delayed weight gain, also observed by Miller et al.,
and w re also reflected in lower fat accumulation in BAT and WAT following an 8-week intervent on.
Adipose tissues function as specialized energy s rvoirs [26] and re apable of expanding to
accommodate excess en rgy in the form of lipids [27]. However, what causes the obesity-induced
inflammat ry re ponse in adipo e tissue is still debated, though it is thought t be related to
cellular injury during adipocyte expansion to accommodate a g eater volume of triglycerides [28].
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Another possible mechanism is that intake of dietary fat up-regulates inflammatory pathways, with
saturated fatty acids stimulating the NF-κB pathway [29], possibly via saturated fatty acid binding
to Toll-like receptors [30]. Earlier it was found that feeding fish oil, and EPA and DHA individually
reduced inflammation in rodent models [28], supporting the likelihood that HFD-ED fed mice were
likely to be less exposed to inflammation compared to the mice fed HFD-corn oil.
Determination of fat content and its distribution clearly shows incorporation of EPA and DHA
in the phospholipid membrane and lower linoleic and arachidonic acid in the neutral lipid fraction
from mice fed HFD-ED, suggesting that not only does EPA and DHA get incorporated into adipocyte
membranes, but could also have a downstream effect on production of pro-inflammatory lipid
mediators derived from linoleic and arachidonic acid. Lower amounts of arachidonic acid in the
phospholipid fraction of adipose tissue in HFD-ED fed mice coupled with down-regulation of genes
coding for phospholipase and several members of cytochrome P450 family suggested that the HFD
did not stimulate prostaglandin-mediated inflammation in the presence of EPA and DHA to the
same extent, as mice fed HFD-corn oil. Nevertheless, increased arachidonic acid levels in tissue
phospholipids of HFD-corn oil fed mice, could suggest increase in the arachidonic acid derived
eicosanoids such as 2-arachidonoylglycerol and anandamide that are linked with increased food
intake, feed efficiency, and obesity development [31]. Another study suggests that the relationship
between these fatty acids is bell shaped—that is, at low levels of EPA and DHA, arachidonic acid is
closely correlated (concentrations not affected), while at high EPA and DHA levels, there is a negative
relationship [32]. Supplementation of EPA and DHA in a high fat diet reduced liver and adipose
tissue phospholipid arachidonic acid content [31,33]. This supports our finding that EPA and DHA
reduces phospholipid arachidonic acid in adipose tissue, an outcome we also found in liver, skeletal
muscle and spleen [23,34,35]. If anti-inflammatory effects can still be observed when arachidonic acid
is correlated with EPA and DHA at lower doses, then possibly other mechanisms may play a greater
role [23] in stimulating inflammation rather than the change in membrane fatty acid composition per
se. The EPA/DHA diet stimulated many pathways related to energy metabolism, and β-oxidation in
particular—which also play a role in regulating the inflammatory response [36].
Up-regulation of BPs related to mitochondria and energy metabolism including the electron
transport chain, and FA β-oxidation, in mice fed HFD-ED compared with HFD-corn oil point to an
important effect on energy metabolism. Analysis of pathway up-regulation supports the up-regulation
of fat metabolism, with regulation of the AMP activated kinase pathway which regulates metabolic
fuel selection [37], HIF-1 (Hypoxia-inducible factor-1), which regulates oxidative metabolism [38],
pyruvate metabolism and FoxO (Forkhead box protein) pathway, which could link EPA and DHA to
insulin signaling [39]. An effect on glucose metabolism is further indicated by regulation of the TCA
cycle, glycolysis and branched chain amino acid degradation, which all point to effects on glucose
metabolism alongside the change to fat metabolism. Follow-up work should include measurements of
insulin secretion and sensitivity, especially given the large number of studies that postulate a role for
EPA and DHA in improvement of T2D. However, it should be noted that a relationship between LC
n-3 PUFA intake from a variety of sources is not conclusively linked to any reduced risk of T2D [40],
though the number of clinical trials studying this is limited [41]. The conclusions of the gene array
data are strengthened by the differential adipose tissue expression of Pparα, Pparγ1a, and Prdm16
involved in β-oxidation, lipogenesis and thermogenesis, respectively. Ppar:s are believed to be primary
mediators of the effects of EPA and DHA. Ppar-α was increased in BAT of HFD-ED fed mice and
Prdm16, in accordance with Pahlavani et. al. [7] who observed increased gene expression in BAT, but
not in WAT.
The widespread upregulation of energy metabolism would be expected to result in increased
metabolic rate—something that was not measured in the present study. Some clinical trials have found
that fish oil supplementation can increase metabolic rate [42], while others have not found any effect [43].
One human study found that while resting metabolic rate was marginally increased by 3 g EPA and
DHA/day, there was no effect on FA oxidation [44], which does not support β-oxidation mediated
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increase in energy expenditure. The wide diversity of results highlights the need for follow-up studies
that can specifically address these potential mechanisms, and also the inherent problems of translating
mechanisms found in rodent models to outcomes in human intervention trials.
4. Materials and Methods
4.1. Animals and Ethical Declaration
Six-week-old male C57BL/6J mice were purchased from the Harlan Laboratories in the Netherlands.
They were caged 5–6 per group and acclimatized for three weeks at a local animal facility with 12 h
light/dark cycles in Gothenburg, Sweden. They had ad libitum access to study chow (see diet composition
for details) and water as previously reported [23]. Two groups were fed a high fat diet to induce obesity,
while the third group ate a standard rodent chow and served as a control group. After 8 weeks of
dietary intervention, the mice were anaesthetized with > 60 mg/kg intraperitoneal injection of sodium
pentobarbital and blood was collected from the heart followed by cervical dislocation. Tissues including
WAT and BAT were dissected, weighed and snap-frozen in liquid nitrogen and stored at −80 ◦C
until further use. The study was approved in 2009 by the Animal Ethical Committee at University of
Gothenburg, Sweden (Study approval number: 253-2009) [23].
4.2. Diet Composition
Mice were fed standard chow (control group) or one of two HFDs that differed only in fatty acids
(FAs), whereas other macronutrients were kept the same (Table 2). Briefly, part of the fat component
of HFD-corn oil was prepared with 5 % (w/w) corn oil, while in the HFD-ED, this 5 % was prepared
with 2 % (w/w) EPAX (n-3 enriched) oils (EPA; EPAX 1050 and DHA; EPAX 6015; EPAX AS, Lysaker,
Norway) and 3 % (w/w) corn oil. Hence, in the HFD-ED diet, the corn oil was replaced with 40% EPA
and DHA containing triglycerides and 2 % of the diet overall consisted of EPA and DHA. The diet
was prepared at Lantmännen AB (Kimstad, Sweden). The feed supply in the cages was changed three
times per week during the course of the study.
4.3. RNA Isolation, Quality Assurance and Microarray Analysis
White and brown adipose tissues from four different mice were selected for total RNA isolation and
microarrays based on the similarity in their body weight, plasma triglyceride, and plasma cholesterol
levels (supplementary Table S1). In brief, total RNA was purified using the RNeasy® Plus Universal
Mini kit (Qiagen Nordic, Sollentuna, Sweden) following the manufacturer’s instructions. RNA integrity
was estimated using RNA 6000 Nano LabChip for Agilent 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, California, USA). RNA was quantified by NanoDrop 2000c UV-Vis Spectrophotometer
(Thermo Scientific, Wilmington, NC, USA).
Microarray experiments were carried out by the SCIBLU Genomics core facility (Swegene Centre for
Integrative Biology at Lund University, Sweden). Briefly, at the facility, the total RNA was labelled and
hybridized to MouseWG-6_V2.0 Expression BeadChip (MouseWG-6_V2.0_R3_11278593_A; Illumina,
San Diego, CA, USA) containing 45,281 transcripts. The data (raw and normalized) are deposited in
SOFT-format at Gene Expression Omnibus (GEO) database under the accession number GSE76622.
Mean intensities from the array fluorescence signals were calculated from illumina bead array
files using GenomeStudio Gene Expression software (GSGX v1.9.0). The data was quantile normalized,
and variance-stabilizing transformation (VST) was performed using the default setting of lumiExpresso
function from lumi package, v2.18.0 [45]. The Empirical Bayes method from the Linear Models for
Microarray Data (limma) package was then applied to the signals to calculate moderated t- and
F-statistics, log odds and differential expression for comparisons between the diets from both adipose
tissues [46].
A platform for integrative analysis of omics data (Piano) Bioconductor package v.3.0 was used for
gene set enrichment analysis (GSEA) for functional inference [47]. Before implementing the gene-set
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enrichment function from Piano, gene-set collection (gsc) files were prepared for gene ontologies (GO)
related to Biological Processes (BPs), Molecular Function (MF) and Cellular Component (CC), and
also for GO related to immune system process (GO:0002376). The Piano package was implemented
for both global and immune related changes on WAT together with BAT for all diet combinations.
In both gene-set analysis, gene-sets with less than 10 and more than 500 genes were excluded.
For gene-expression analysis, Benjamini and Hochberg (BH) corrected p-value < 0.001 for at least one
diet comparison was considered significant. The Generally Applicable Gene-Set/Pathway Analysis
(GAGE) bioconductor package was used for pathway enrichment analysis [48]. Before implementing
the gage function, canonical signalling and metabolic pathways from the KEGG mouse database were
prepared for better-defined results. The Pathview package, v1.10 was used to visualize the data, in
which the pathview function downloads KEGG graph data and renders a pathway map, based on
experimental results [49]. The top 20 significantly enriched pathways were plotted as barplots and
FDR corrected p-values (q-values) data were transformed to −log10(padj-value).
4.4. RT-qPCR Analyses of Selected Genes
4.4.1. Samples
Total RNA in BAT and WAT from three animals (n = 3) in the low-fat control, HFD-CO, and
the HDF-ED groups were analyzed using a gene expression profiling service (TATAA Biocenter,
Gothenburg, Sweden).
4.4.2. Quality Control
The concentration and purity of the samples was measured spectrophotometrically with the
Dropsense96 (Unchained Labs, Pleasanton, CA, USA. The RNA integrity was analyzed using capillary
gel electrophoresis on the Fragment Analyzer (Agilent, Santa Clara, CA, USA) and the Standard
Sensitivity RNA kit (Agilent, Cat No. DNF-471-0500). All RNA samples except for one sample from
WAT in the HDF-ED group, passed the quality check. The data originating from the faulty sample
were excluded in the statistical analyses.
4.4.3. Normalization and cDNA Synthesis
The RNA samples were reverse transcribed using the GrandScript cDNA synthesis kit (TATAA
Biocenter, Cat No. A103b, TATAA Biocenter AB, Gothenburg, Sweden according to manufacturer’s
instructions in single 20 µL reactions. Prior to the reverse transcription all samples where normalized
to 200 ng/µL; giving a total input of 1000 ng RNA into the reverse transcription reaction. 5 µL of
samples with concentrations lower than 200 ng/µL where loaded directly without normalizations.
Water was used as RT-NTC and included in the analysis. The cDNA samples were diluted 10 times in
RNase free water and analyzed on all 12 assays in the TATAA Mouse Reference Gene Panel (TATAA
Biocenter, Cat No. A102P).
4.4.4. cDNA Synthesis and qPCR
Mouse ValidPrime assay (TATAA Biocenter, Cat No. A106P25) was used to compensate for
possible gDNA contamination and mouse gDNA (Bioline, Cat No. BIO-35027) was included in the
analysis. NTCs were included as a control for contamination of reagents and all samples were run
in duplicates. The master mixes were prepared with TATAA Probe Low ROX GrandMaster Mix
(TATAA Biocenter, Cat No. TA02-625LR). All pipetting was performed by a pipetting robot (EpMotion
5070, Eppendorf, Hamburg, Germany. The qPCR was run on the Quantstudio 12K Flex platform
(ThermoFisher, Waltham, MA, USA. The Cq values were determined using the relative thresholding
method in the Quantstudio 12K Flex Software (ThermoFisher, Waltham, MA, USA, after which GenEx
(MultiD) version 7.0.2.164 was used to perform data pre-processing including ValdPrime correction.
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The two most suitable reference genes were evaluated using the NormFinder and GeNorm algorithms.
The final selection of the two best reference genes was made using NormFinder.
4.4.5. Gene Expression Profiling
Three Bio-Rad assays targeting Genes of interest GOIs (Table 3), two reference gene assays and
ValidPrime (TATAA Biocenter, Cat No. A106P25) were used for expression profiling of the mouse
samples. cDNA was diluted 3 times before qPCR. RNase free water was used as an NTC and included
along with RT-NTC and mouse gDNA (Bioline, Cat No. BIO-35027, London, UK in the analysis.
The master mixes were prepared with TATAA Probe Low ROX GrandMaster Mix (TATAA Biocenter,
Cat No. TA02-625LR). All pipetting was performed by a pipetting robot (EpMotion 5070, Eppendorf).
The qPCR was run on the Quantstudio 12K Flex platform (ThermoFisher). The Cq values were
determined using the relative threshold method in the Quantstudio 12K Flex Software (ThermoFisher),
after which GenEx (MultiD) was used to perform data preprocessing and to calculate the data Cq for
the GOIs relative to reference genes.
Table 3. Bio-Rad assays targeting Genes of interest (GOIs).
Target Gene Assay ID Probe Dye Comment
Pparα qMmuCEP0054952 FAM GOI
Pparγ1a qMmuCIP0030057 FAM GOI
Prdm16 qMmuCEP0057138 FAM GOI
4.5. Fatty Acid Analysis by Gas-Chromatography Mass Spectrometry
Approximately, 100 mg WAT and BAT tissues were weighed and freeze-dried for FA extraction
using the Folch total lipid extraction method [50]. Neutral lipids, free fatty acids, and phospholipid
fractions were separated, and each fatty acid fraction was quantified using gas chromatography mass
spectrometry (GC-MS), as previously described [23]. Fatty acids were quantified against internal
phospholipid (C17:0) and triglyceride (C19:0) standards (Nu-Chek Prep, Inc., Elysian, MN, USA) and
was expressed as relative percentage of total lipid fractions. The fatty acid methyl esters (FAME)
were separated by gas chromatography (Agilent 7890A, Santa Clara, CA) and detected with mass
spectroscopy. Chemstation software (Agilent Technologies, Santa Clara, CA) was used for evaluation.
The samples were separated on a VF-WAX (30 × 0.25 × 0.25 µm dF) column (Agilent Technologies) and
detected with a 5975C inert mass spectrometer (Agilent Technologies).
4.6. Statistical Analysis
Physiological data were considered different for p-value < 0.05 based on one-way ANOVA with
post-hoc Tukey-Honest significant difference test (Tukey-HSD). For the microarray data and GSEA,
BH adjusted p-value < 0.001 was considered significant and used as a cut-off value for considering
data for biological interpretation. The data are presented as mean ± SEM. Statistical and microarray
data were analysed in the R Studio environment (Version 0.99.903—© 2009-2016 RStudio, Inc.) using
Bioconductor packages.
5. Conclusions
HFD-ED fed mice showed reduced lipid accumulation and levels of the pro-inflammatory
fatty acid arachidonic acid in both white and brown adipose tissues, compared with HFD-corn oil
fed animals. The transcriptomic analysis showed changes in β-oxidation pathways, supporting the
decreased lipid accumulation in the HFD-ED fed mice. Therefore, our data suggests that EPA and DHA
supplementation of a high fat diet may be anti-inflammatory, as well as reduce lipid accumulation in
adipose tissues.
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